HERON THERAPEUTICS INC (HRTX) Stock Income Statement
NASDAQ:HRTX - Nasdaq - US4277461020 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 144.28M | 127.04M | 107.70M | 86.30M | 88.60M | |||
| Cost Of Goods | 38.65M | 65.11M | 54.90M | 46.00M | 36.20M | |||
| Gross Profit | 105.64M | 61.94M | 52.80M | 40.30M | 52.40M | |||
| Operating Expenses | 117.17M | 172.55M | 227.40M | 258.20M | 280.60M | |||
| Research and Development | 16.68M | 55.90M | 107.50M | 130.80M | 174.50M | |||
| Selling, General, and Administrative Expenses | 100.48M | 116.66M | 120.00M | 127.30M | 106.10M | |||
| Operating Income | -11.53M | -110.61M | -174.70M | -217.80M | -228.20M | |||
| Interest Income/Expense | -2.48M | -504.00K | -800.00K | -2.00M | 1.70M | |||
| Other Income/Expense | 430.00K | 560.00K | -6.50M | -900.00K | -800.00K | |||
| Income Before Taxes | -13.58M | -110.56M | -182.00M | -220.70M | -227.30M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -13.58M | -110.56M | -182.00M | -220.70M | -227.30M | |||
| EBITDA | -9.04M | -107.72M | -171.81M | -214.78M | -225.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -0.80 | -1.67 | -2.24 | -2.50 | |||
| Non GAAP EPS | -0.09 | -0.86 | -1.73 | -2.25 | -2.50 | |||
| Statistics | ||||||||
| Gross Profit Margin | 73.21% | 48.75% | 49.03% | 46.70% | 59.14% | |||
| Profit Margin | -9.41% | -87.02% | -168.99% | -255.74% | -256.55% | |||
| Operating Profit Margin | -7.99% | -87.07% | -162.21% | -252.38% | -257.56% | |||
All data in USD